Article Listing - Jazz completes Orphan Medical buy

VIETNAM PHARMA PRODUCTION STRONG

16 March 1992

A recent meeting on pharmaceutical production in provinces in southern Vietnam in 1991 concluded that the year was a highly...

MORE ICI PUERTO RICO INVESTMENT

16 March 1992

Imperial Chemical Industries' subsidiary IPR Pharmaceutical Inc is to make a new investment of $10 million in the development of...

FRENCH, GERMAN, SWISS HEALTH CARE COSTS

16 March 1992

Health care spending continues to rise remorselessly in Germany and France, although control measures are having partial success.

New figures from...

PRODUCTION STOPS AT POLISH PLANT

16 March 1992

Production at the Rzeszow factory of the Polfa pharmaceutical enterprise has stopped, because the facility has not received $23 million...

GERMANY'S HOECHST, BAYER PROFITS DOWN

16 March 1992

German chemical/pharmaceutical groups reporting 1991 results last week, despite profit declines and dividend cuts, saw their share prices rise.

Among...

NOVO REPORTS 28% PRETAX PROFIT JUMP

16 March 1992

Danish drugmaker Novo Nordisk saw 1991 pretax income jump 28% to 1.46 billion Danish kroner ($226.4 million), on sales up...

US APPRO FOR ISIS' ANTISENSE TRIAL

16 March 1992

- Isis Pharma has received US Food and Drug Administration approval to begin human clinical trials with an anti-sense compound....

ACF 1991 RESULTS

16 March 1992

- Dutch pharmaceutical wholesaler ACF Holding NV reports that 1991 net profit was boosted 68% to 23.8 million guilders ($12.7...

SANDOZ' NEW US RESEARCH CENTER

16 March 1992

- Sandoz Pharma has opened a new $50 million, 167,000 square foot research center in East Hanover, New Jersey, to...

SALE OF FERMENTA'S INDEPENDENT

16 March 1992

- A consortium of Swedish banks is to buy Fermenta's financial subsidiary Independent for one billion Swedish kroner ($169 million),...